We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Syzygy Plasmonics Stock

Invest in or calculate the value of your shares in Syzygy Plasmonics or other pre-IPO companies through EquityZen's platform.

Get Started

Syzygy Plasmonics Stock (SYPL)

Syzygy Plasmonics is a developer of a photocatalytic reactor designed for fuel cell vehicles and small-scale industrial applications.

About Syzygy Plasmonics Stock

Founded

2017

Headquarters

Houston, TX, US

Industries

Software, Data and Analytics, Artificial Intelligence

Syzygy Plasmonics is a developer of a photocatalytic reactor designed for fuel cell vehicles and small-scale industrial applications.The company's reactor is powered by light and operates at over 1,000°F lower temperature than conventional chemical reactor technology that helps in reducing maintenance costs and is able to start or stop production near instantaneously, enabling fuel cell vehicle companies to produce ultra-low-cost hydrogen gas on-site at customer locations.

Syzygy Plasmonics Management

Leadership team at Syzygy Plasmonics

Director Governance Risk and Assurance

Thomas Henry

Co-Founder and Chief Technology Officer

Suman Khatiwada

Locked Features

Join now and verify your accreditation status to gain access to:

  • Syzygy Plasmonics current valuation
  • Syzygy Plasmonics stock price
  • Available deals in Syzygy Plasmonics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Syzygy Plasmonics stock?

Accredited investors can buy pre-IPO stock in companies like Syzygy Plasmonics through EquityZen funds. These investments are made available by existing Syzygy Plasmonics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Syzygy Plasmonics stock?

Shareholders can sell their Syzygy Plasmonics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Syzygy Plasmonics